MALKAN, Ü. Y. Et Al. 2015. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4 , 215-221.

MALKAN, Ü. Y., AKSU, S., Aktimur, S. H., Atay, H., Bektas, Ö., BÜYÜKAŞIK, Y., ... DEMİROĞLU, H.(2015). Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, 215-221.

MALKAN, ÜMİT Et Al. "Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, 215-221, 2015

MALKAN, ÜMİT Y. Et Al. "Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, pp.215-221, 2015

MALKAN, Ü. Y. Et Al. (2015) . "Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, pp.215-221.

@article{article, author={ÜMİT YAVUZ MALKAN Et Al. }, title={Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2015, pages={215-221} }